Reference
Booth N, et al. Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data. PLOS One : 5 Nov 2019. Available from: URL: https://doi.org/10.1371/journal.pone.0224479
Rights and permissions
About this article
Cite this article
PSA-based screening program may not be cost effective. PharmacoEcon Outcomes News 842, 23 (2019). https://doi.org/10.1007/s40274-019-6415-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6415-3